SWOG 1826-A Phase III, Randomized Study of Nivolumab (Opdivo) plus AVD or Brentuximab Vedotin (Adcetris) plus AVD in Patients (Age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

January 06, 2020
Cancer - Lymphoma
Principal Investigator: Haythem Y Ali, MD
Advanced classical Hodgkin lymphoma, advanced Hodgkin lymphoma, newly diagnosed Hodgkin lymphoma
Accepting Participants